ASP Isotopes (NASDAQ:ASPI) Stock Price Up 8% - What's Next?

Key Points

• ASP Isotopes shares jumped about 8% on Friday to $4.546, but the move occurred on very light volume (≈510,470 shares versus a ~5.18M daily average), suggesting limited market participation.
• Analyst sentiment is mixed — the consensus rating is "Hold" with a $13 target (two Buys, one Sell) and Weiss Ratings reiterated a "sell (d-)"; the company has a market cap of ~$490M, a negative P/E (-3.40) and a high beta (3.59).
• Insiders remain significant holders (14.4% ownership); the COO sold 8,438 shares at $5.44, and institutional ownership is about 16.8%.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) rose 8% on Friday . The stock traded as high as $4.54 and last traded at $4.5460. Approximately 510,470 shares traded hands during trading, a decline of 90% from the average daily volume of 5,182,098 shares. The stock had previously closed at $4.21.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a "sell (d-)" rating on shares of ASP Isotopes in a research note on Friday, March 27th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, ASP Isotopes presently has a consensus rating of "Hold" and a consensus target price of $13.00.

ASP Isotopes Stock Up 5.1%

The firm has a 50 day simple moving average of $5.16 and a two-hundred day simple moving average of $6.98. The company has a quick ratio of 6.10, a current ratio of 6.14 and a debt-to-equity ratio of 1.04. The stock has a market capitalization of $490.47 million, a P/E ratio of -3.40 and a beta of 3.59.

Insider Activity at ASP Isotopes

In other news, COO Robert Ainscow sold 8,438 shares of the stock in a transaction on Friday, March 6th. The stock was sold at an average price of $5.44, for a total value of $45,902.72. Following the completion of the transaction, the chief operating officer directly owned 1,537,817 shares in the company, valued at approximately $8,365,724.48. This represents a 0.55% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 14.40% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new stake in ASP Isotopes during the 3rd quarter worth about $34,000. BNP Paribas Financial Markets grew its holdings in ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company's stock worth $41,000 after acquiring an additional 2,548 shares during the period. IFP Advisors Inc acquired a new stake in ASP Isotopes during the 4th quarter worth about $48,000. Pictet Asset Management Holding SA acquired a new stake in ASP Isotopes during the 4th quarter worth about $61,000. Finally, Close Asset Management Ltd acquired a new stake in ASP Isotopes during the 3rd quarter worth about $72,000. 16.80% of the stock is owned by institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.